Pfizer's MenABCWY shot – which combines its MenACWY vaccine Nimenrix with and MenB jab Trumenba – will now be filed for FDA approval in adolescents and young adults in the fourth quarter of ...
On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine ... Although MenB is the leading cause of IMD among this population ...
Effective vaccines are available against the ACWY groups (MenACWY), alongside separate MenB vaccines. However, despite successful vaccination programmes in some countries, uptake is patchy ...
In most cases, childhood vaccinations would have included a meningitis vaccine that protected against MenACWY, but not MenB. Call the Student Health & Wellness Centre at 902-494-2171 to book vaccine ...
GSK’s chief scientific officer, Tony Wood, said that the results show the vaccine protects against “the broadest panel of circulating MenB strains to date,” adding that MenB is “the most ...
The FDA approved GSK's Penmenvy vaccine for ages 10-25 ... have issued recommendations. Although MenB is the leading cause of IMD among this population, less than 13% receive the recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results